Galectin Therapeutics Inc. Common Stock (GALT)

$2.6 +8.79%
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-08-14 ESTIMATED
search

Galectin Therapeutics Inc. Common Stock (GALT) has reported earnings 20 times since May 17, 2021. The stock moves an average of ±5.33% the day after reporting, closing higher 55.0% of the time. Its largest post-earnings gain was +8.35% (Mar 31, 2026) and its largest decline was -19.41% (Mar 31, 2025). The next earnings report is predicted for 2026-08-14 (estimated).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

20

Avg Abs. Movement

±5.33%

Positive %

55.0%

Negative %

45.0%

Historical Earnings Statistics

Date Timing Open High Close Volume Movement % SEC Filing
May 15, 2026 ☀ PRE $2.26 $2.26 $2.18 19,435 -7.43% open_in_new
Mar 31, 2026 ☀ PRE $2.75 $2.80 $2.79 8,629 +8.35% open_in_new
Nov 14, 2025 ☀ PRE $5.18 $5.64 $5.55 6,614 +0.91% open_in_new
Aug 14, 2025 ☀ PRE $3.75 $3.77 $3.76 5,172 +2.59% open_in_new
May 15, 2025 ☀ PRE $1.31 $1.36 $1.32 3,664 +0.76% open_in_new
Mar 31, 2025 ☀ PRE $1.27 $1.36 $1.23 27,649 -19.41% open_in_new
Nov 14, 2024 ☀ PRE $2.92 $2.92 $2.83 2,706 -2.92% open_in_new
Aug 13, 2024 ☀ PRE $2.19 $2.27 $2.24 7,606 +5.66% open_in_new
May 15, 2024 ☀ PRE $2.88 $3.12 $3.06 8,532 +7.37% open_in_new
Nov 13, 2023 ☀ PRE $1.97 $1.98 $1.95 2,111 -6.25% open_in_new
Aug 14, 2023 ☀ PRE $1.47 $1.47 $1.47 320 +4.26% open_in_new
May 15, 2023 ☀ PRE $1.65 $1.65 $1.65 104 -4.91% open_in_new
Mar 30, 2023 ☀ PRE $2.08 $2.13 $2.13 1,445 +3.9% open_in_new
Nov 14, 2022 ☀ PRE $1.14 $1.14 $1.14 0 +0% open_in_new
Aug 15, 2022 ☀ PRE $2.17 $2.17 $2.17 448 +4.33% open_in_new
May 16, 2022 ☀ PRE $1.27 $1.27 $1.27 200 -5.9% open_in_new
Mar 31, 2022 ☀ PRE $1.69 $1.69 $1.59 2,392 -8.33% open_in_new
Nov 15, 2021 ☀ PRE $2.89 $2.89 $2.81 2,745 -6.64% open_in_new
Aug 16, 2021 ☀ PRE $3.30 $3.33 $3.30 1,276 -2.94% open_in_new
May 17, 2021 ☀ PRE $4.35 $4.56 $4.37 17,341 +3.8% open_in_new
event

Earnings Count

20

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.33%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

3 most recent
Form Date Filed View on EDGAR
4 20260528 open_in_new SEC.gov
10-Q 20260515 open_in_new SEC.gov
8-K 20260515 open_in_new SEC.gov

Frequently asked about GALT earnings

When does Galectin Therapeutics Inc. Common Stock report earnings next? expand_more

Galectin Therapeutics Inc. Common Stock (GALT)'s next earnings date is estimated for 2026-08-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does GALT stock move after earnings? expand_more

Over 20 reports, GALT has moved an average of ±5.33% the session after earnings, closing higher 55.0% of the time.

What was GALT's biggest post-earnings move? expand_more

GALT's largest post-earnings gain on record was +8.35% on Mar 31, 2026, and its largest decline was -19.41% on Mar 31, 2025.

Where can I find Galectin Therapeutics Inc. Common Stock's SEC filings? expand_more

All of Galectin Therapeutics Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers